MicroRNA-21 restrains myD88-dependent protective inflammation worsening Staphylococcus aureus skin infection

Area of Science:

• Immunology
• Microbiology
• Molecular Biology

Background:

• Staphylococcus aureus skin infections involve complex immune responses.
• MicroRNAs regulate inflammatory pathways crucial for infection control.
• Maintaining a balance between inflammation and tissue repair is vital.

Purpose of the Study:

• To investigate the role of microRNA-21 (miR-21) in Staphylococcus aureus skin infections.
• To evaluate the therapeutic potential of targeting miR-21 for treating S. aureus infections.

Main Methods:

• Utilized mouse models of S. aureus skin infection.
• Administered topical miR-21 antagomirs.
• Generated myeloid cell-specific miR-21 knockout mice (miR21 Δmyel).
• Assessed bacterial load, lesion size, immune cell infiltration, and mediator levels (e.g., IL-1β, TNF, IL-33, IL-10).
• Investigated the involvement of the MyD88 pathway.

Main Results:

• S. aureus infection increased miR-21 levels in the skin.
• Topical miR-21 inhibition improved bacterial clearance and infection resolution.
• miR21 Δmyel mice exhibited reduced lesion size and bacterial burden.
• miR-21 modulated key inflammatory mediators.
• miR-21 deficiency increased MyD88 expression, which was critical for the observed protective effects.

Conclusions:

• The miR-21/MyD88 pathway is a critical regulator of inflammation resolution and antibacterial immunity in S. aureus skin infections.
• Targeting miR-21 presents a promising therapeutic strategy for antibiotic-resistant S. aureus infections.